Rectal cancer
Rectal cancer refers to cancer located between the dentate line and the junction of the sigmoid colon and rectum. It is one of the most common malignant tumors in the gastrointestinal tract. The main manifestations are dull abdominal pain and abdominal discomfort; when rectal cancer progresses to the late stage, there will be obvious lower abdominal pain. As the disease progresses and the tumor grows to a certain extent, the patient will experience systemic symptoms such as anemia and weight loss. Its incidence rate ranks third among malignant tumors in the world. In 2011, the incidence rate in my country was about 23/100,000, and the mortality rate was about 11/100,000, and it has been increasing year by year. However, the early colorectal symptoms are not obvious, and most patients are already in the late stage when diagnosed. The 5-year survival rate of such patients is less than 10%. More than 90% of the cases are over 40 years old. The incidence rate of colorectal cancer in men and women is similar worldwide, with men slightly higher than women.
Related Drugs
Calcium folinate tablets
Indication: 1. Used as an antidote for folic acid antagonists (such as methotrexate, pyrimethoprim or trimethoprim). 2. Used to prevent severe toxic effects caused by overdose or high-dose treatment with methotrexate. 3. Also used to treat megaloblastic anemia caused by folic acid deficiency. 4. Used in combination with 5-fluorouracil for advanced colon and rectal cancer.
Manufacturer:
Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd.
Calcium folinate tablets
Indication: It is used to prevent toxic symptoms caused by treatment with moderate to high doses of methotrexate or sustained high serum concentrations of methotrexate (including treatment with low doses of methotrexate). It is used to treat toxic symptoms caused by folinic acid deficiency due to methotrexate treatment.
Calcium folinate tablets
Indication: 1. Used as an antidote for folic acid antagonists (such as methotrexate, pyrimethoprim or trimethoprim). 2. Used to prevent severe toxic effects caused by overdose or high-dose treatment with methotrexate. 3. Also used to treat megaloblastic anemia caused by folic acid deficiency. 4. Used in combination with 5-fluorouracil for advanced colon and rectal cancer.
Manufacturer:
Shenzhen Zhonglian Pharmaceutical Co., Ltd.
Calcium folinate tablets
Indication: 1. Used as an antidote for folic acid antagonists (such as methotrexate, pyrimethoprim or trimethoprim). 2. Used to prevent severe toxic effects caused by overdose or high-dose treatment with methotrexate. 3. Also used to treat megaloblastic anemia caused by folic acid deficiency. 4. Used in combination with 5-fluorouracil for advanced colon and rectal cancer.
Manufacturer:
Changchun Tiancheng Pharmaceutical Co., Ltd.
Calcium folinate tablets
Indication: 1. Mainly used as an antidote for folic acid antagonists (such as methotrexate, pyrimethamine or trimethoprim, etc.). 2. Used to prevent severe toxic effects caused by overdose or high-dose treatment of methotrexate. 3. Megaloblastic anemia caused by folic acid deficiency. 4. When used in combination with fluorouracil, it is used to treat advanced colon cancer and rectal cancer.
Calcium folinate
Indication: Used in combination with 5-fluorouracil for the treatment of gastric cancer and colorectal cancer.
Manufacturer:
Guangdong Lingnan Pharmaceutical Co., Ltd.
Calcium folinate
Indication: Used in combination with 5-fluorouracil for the treatment of gastric cancer and colorectal cancer.
Manufacturer:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Calcium folinate
Indication: Used in combination with 5-fluorouracil for the treatment of gastric cancer and colorectal cancer.
Manufacturer:
Qilu Pharmaceutical Co., Ltd.
Tegafur Suppository
Indication: Anti-tumor drug used for digestive tract tumors, breast cancer, bronchial lung cancer and liver cancer, etc.
Manufacturer:
Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co., Ltd.
Oxaliplatin
Indication: Combined with 5-fluorouracil and folinic acid (leucovorin): first-line treatment of metastatic colorectal cancer; adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of the primary tumor. This indication is based on the results of foreign clinical studies.
Manufacturer:
Shenzhen Neptunus Pharmaceutical Co., Ltd.